JamesL MFerraraMD

PubMed

• 219 citations
  Histone deacetylase inhibitor suberoylanilide hydroxamic acid reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect
  Pavan Reddy, Yoshinobu Maeda, Kevin B. Hotary, Chen Liu, Leonid L. Reznikov
  Proceedings of the National Academy of Sciences of the United States of America. 2004-03-16
• 766 citations
  An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation : I. The roles of minor H antigens and endotoxin
  Kenneth R. Cooke, Lester Kobzik, Thomas R. Martin, Joanne P. Brewer, John Delmonte
  Blood. 1996-10-15
• 202 citations
  Differential roles of IL-1 and TNF-α on graft-versus-host disease and graft versus leukemia
  Geoffrey R. Hill, Takanori Teshima, Armin Gerbitz, Luying Pan, Kenneth R. Cooke
  The Journal of Clinical Investigation. 1999-08-15

Journal Articles

• Efficacy of a cyclophosphamide-procarbazine-antithymocyte serum regimen for prevention of graft rejection following bone marrow transplantation for transfused p...  
  Smith BR, Guinan EC, Parkman R, Ferrara JLM, Levey RH, Nathan DG, Rappeport JM, Transplantation
• Cutaneous acute graft-versus- host disease to minor histocompatibility antigens in a murine model: Histologic analysis and correlation to clinic disease.  
  Ferrara JLM, Guillén FJ, Sleckman B, Burakoff SJ, Murphy GF, J Invest Dermatol
• Acute cutaneous graft-versus-host disease to minor histocompatibility antigens in a murine model: Evidence that large granular lymphocytes are effector cells...  
  Guillén FJ, Ferrara JLM, Hancock WW, Messadi D, Fonferko E, Burakoff SJ, Murphy GF, Lab Invest
• Bone marrow transplantation: The genetic and cellular basis of resistance to engraftment and acute graft-versus-host-disease.  
  Ferrara JLM, Mauch P, Murphy G, Burakoff SJ, Surv Immunol Res
• Amelioration of acute graft versus host disease due to minor histocompatibility antigens by in vivo administration of anti- Interleukin 2 receptor antibody.  
  Ferrara JLM, Marion A, McIntyre JF, Murphy GF, Burakoff SJ, J Immunol
• Acute graft-versus-host-disease: Pathogenesis and prevention with a monoclonal antibody in vivo.  
  Ferrara JLM, Marion A, Murphy G, Burakoff SJ, Transplant Proc
• Relationship of the genes for Chediak-Higashi syndrome (Beige) and the T cell Receptor chain in mouse and man.  
  Holcombe RF, Strauss W, Owen FL, Boxer LA, Warren RW, Conley ME, Ferrara JLM, Leavitt RY, Fauci AS, Taylor BA, Seidman JG, Genomics
• Engraftment following T cell-depleted marrow transplantation. I. The role of major and minor histocompatiblity barriers.  
  Ferrara JLM, Lipton J, Hellman S, Burakoff S, Mauch P, Transplantation
• Functional T cell deficits after bone marrow transplantation across minor histocompatibility barriers. Effects of graft-versus-host-disease on precursor frequency...  
  Ferrara JLM, Daley JP, Burakoff SJ, Miller RA, J Immunol
• Engraftment following T cell depleted bone marrow transplantation. II. Stability of mixed chimerism in semiallogeneic recipients after total body irradiation.  
  Ferrara JLM, Mauch P, McIntyre J, Michaelson J, Burakoff SJ, Transplantation
• Efficient conjugation of DTPA to an IgM monoclonal antibody in ascites fluid.  
  Kinsey GM, Macklis RM, Ferrara JLM, Layne WW, Burakoff SJ, Kassis AI, Nucl Med Biol
• Engraftment following T cell depleted bone marrow transplantation. III. Differential effects of increased body irradiation on semiallogeneic and allogeneic recipients.  
  Ferrara JLM, Michaelson J, Burkoff SJ, Mauch P, Transplantation
• Immunodeficiency in graft versus host disease.I. Mechanism of immune suppression.  
  Wall DA, Hamberg SD, Reynolds DS, Burakoff SJ, Abbas AK, Ferrara JLM, J Immunol
• Biodistribution studies of anti-Thy 1.2 IgM immunoconjugates: Implications for radioimmunotherapy.  
  Macklis RM, Kaplan WD, Ferrara JLM, Kinsey BM, Kassis AI, Burakoff SJ, Int J Radiat Oncol
• Radioimmunotherapy with alpha-particle-emitting immunoconjugates.  
  Macklis RM, Kinsey BM, Kassis AI, Ferrara JLM, Atcher RW, Hines JJ, Coleman CN, Adelstein SJ, Burakoff SJ, Science
• Stem cell self-renewal considerations in bone marrow transplantation.  
  Mauch P, Ferrara JLM, Hellman S, Bone Marrow Transpl
• Evidence that large granular lymphocytes of donor origin mediate acute graft versus host disease.  
  Ferrara JLM, Guillén FJ, van Dijken PJ, Marion A, Murphy GF, Burakoff SJ, Transplantation
• Developmental regulation of erythropoiesis by hematopoietic growth factors: Analysis on populations of BFU-E from bone marrow, peripheral blood, and fetal liver.  
  Emerson SG, Thomas S, Ferrara JLM, Greenstein JL, Blood
• Late tissue-specific toxicity of total body irradiation and busulfan in a murine bone marrow transplant model.  
  Down JD, Berman AJ, Warhol M, van Dijken PJ, Ferrara JLM, Yeap B, Hellman S, Mauch PM, Int J Radiat Oncol
• Immunodeficiency in graft versus host disease (GVHD). II. Effects of GVHD induced suppressor cells on CD4+ T cell clones.  
  Wall DA, Hamberg S, Ferrara JLM, Abbas AK, J Immunol
• Evidence that anti-asialo GM1 in vivo improves engraftment of T cell depleted bone marrow in hybrid recipients.  
  Ferrara JLM, Mauch P, van Dijken PJ, Crosier KE, Michaelson J, Burakoff SJ, Transplantation
• Evidence that anti-LFA- 1 in vivo improves engraftment and survival after allogeneic bone marrow transplantation.  
  van Dijken PJ, Ghayur T, Mauch P, Down J, Burakoff SJ, Ferrara JLM, Transplantation
• Nuclear magnetic resonance of hepatic graft-versus-host disease in mice.  
  Blatter DD, Crawford JM, Ferrara JLM, Transplantation
• Alloreactive lymphocytes from T cell receptor ( -chain) transgenic mice do not mediate a graft versus host reaction.  
  Rimm IJ, Ghayur T, Gasser DL, Rosenkrantz K, Burakoff SJ, Seidmanm JG, Ferrara JLM, J Immunol
• Inhibition of interleukin-1 by an interleukin-1 receptor antagonist prevents graft- versus-host disease.  
  McCarthy, Jr. PL, Abhyankar S, Neben S, Newman G, Sieff C, Thompson RC, Burakoff SJ, Ferrara JLM, Blood
• Join now to see all

Books/Book Chapters

• Graft-vs.- Host Disease. 
  Chapter: The pathophysiology of graft-vs.-host disease 
  Page 1 - 34Ferrara JLM, Cooke KR, Teshima TEditors: Ferrara.Marcel Dekker, New YorkEdition 3rd,
• Rossi's Principles of Transfusion Medicine. 
  Chapter: Transfusion-associated graft-versus-host disease 
  Levine JE, Ferrara JLMEditors: Simon TL, Snyder EL, Solheim BG, Stowell CP, Strauss RG, Petrides M.AABB PressEdition 4th,
• Mouse models of graft-versus-host disease 
  Chapter: The Stem Cell research Community 
  Reddy P, Ferrara JLMEditors: StemBook, D Mathis and J Ritz.
• Hematology Basic Principles and Practice. 
  Chapter: Graft-versus-host disease and graft-versus-leukemia responses 
  Page 1677 - 1693Reddy P, Ferrara, JLMEditors: Hoffman.Churchill Livingstone, Elsevier, PhiladelphiaEdition 5th,
• Contemporary Hematology, Hematopoietic Stem Cell Transplantation. 
  Chapter: Pathophysiology of acute graft-versus-host disease 
  Page 563 - 588Reddy P, Ferrara JLMEditors: Soiffer RJ.Humana PressEdition 2nd,
• Cancer: principles & practice of oncology. 
  Chapter: Autologous stem cell transplantation 
  Page 2541 - 2546Mineishi S, Ferrara JLMEditors: DeVita VT Jr, Lawrence TS, Rosenberg SA.Lippincott, Williams, & Wilkins, PhiladelphiaEdition 8th,
• GvHD – state of the art. Bremen. 
  Holler E, Dickinson AM, Edinger M, Ferrara JLM, Hahn J, Kolb HJ, Socie GUNI-MED Verlag
• Graft-vs.- Host Disease. 
  Chapter: Recent advances and future directions 
  Page 609 - 630Reddy P, Cooke KR, Ferrara JLM, Deeg HJEditors: Ferrara.Marcel DekkeEdition 3rd,
• Graft-vs.-Host Disease. 
  Chapter: The pathophysiology of lung injury after hematopoietic stem cell transplantation 
  Page 329 - 367Cooke KR, Ferrara JLMEditors: Ferrara.Marcel Dekker, New YorkEdition 3rd,
• Thomas’ Hematopoietic Cell Transplantation. 
  Chapter: The pathophysiology of graft-vs.-host disease 
  Page 208 - 221Ferrara JLM, Antin JHEditors: Appelbaum FR, Forman SJ, Negrin RS, Blume KG.Wiley-Blackwell PublishersEdition 4th,
• Hematology: Basic Principles and Practice. 
  Chapter: Graft-versus-host disease and graft-versus-leukemia effect 
  Page 1783 - 1800Reddy P, Ferrara JLMEditors: Hoffmann.B. Saunders CoEdition 4th,
• Stem Cell Transplantation for Hemotologic Malignancies. 
  Chapter: Pathophysiology of acute GVHD 
  Page 135 - 157Teshima T, Ferrara JLMEditors: Soiffer R.Humana Press
• Clinical Bone Marrow and Blood Stem Cell Transplantation. 
  Chapter: Pathogenesis of acute and chronic graft-versus-host disease 
  Page 227 - 246Teshima T, Ferrara JLMEditors: K Atkinson.Cambridge University Press, New YorkEdition 3rd,
• Hematology for the Medical Student. 
  Chapter: Bone marrow transplantation 
  Page 247 - 258Uberti J, Silver S, Ferrara JLMLippincott Williams & Wilkins
• Thomas’ Hematopoietic Cell Transplantation. 
  Chapter: The pathophysiology of graft-vs.-host disease 
  Page 353 - 368Ferrara JLM, Joseph AntinEditors: Blume KG, Forman SJ, and Applebaum FR.Blackwell PublishingEdition 3rd,
• Current Therapy in Allergy, Immunology, and Rheumatology. 
  Chapter: Practical considerations of immune reconstitution following bone marrow transplantation 
  Page 399 - 404Levine JE, Ferrara JLMEditors: Lichtenstein LM, Busse WW, Geha RS.Mosby PressEdition 6th,
• Therapeutic Immunology. 
  Chapter: Hemopoietic cell transplantation 
  Page 496 - 517Ferrara JLM, Ratanatharathorn VBlackwell Science, LondonEdition 2nd,
• Therapeutic Immunology. 
  Chapter: Hemopoietic cell transplantation 
  Page 496 - 517Ferrara JLM, Ratanatharathorn VBlackwell Science, LondonEdition 2nd,
• Therapeutic Immunology. 
  Chapter: Bone marrow and hemopoietic stem cell transplantation 
  Page 488 - 506Deeg HJ, Ferrara JLMEditors: KF Austin.Blackwell Science
• Graft Versus Host Disease. 
  Chapter: The pathophysiology of acute graft versus host disease in a murine bone marrow transplant model 
  Page 9 - 29Ferrara JLM, Burakoff SJEditors: SJ Burakoff, HJ Deeg, JLM Ferrara, K Atkinson.Marcel Dekker, New York
• Graft Versus Host Disease. 
  Chapter: Introduction 
  Page 3 - 8Ferrara JLM, Burakoff SJEditors: SJ Burakoff, J Deeg, JLM Ferrara, and K Atkinson.Marcel Dekker, New York
• Bone Marrow Purging and Processing. 
  Chapter: Depletion of bone marrow T-lymphocytes with an anti-CD5 monoclonal immunotoxin (ST-1 Immunotoxin): Effective prophylaxis for graft versus host disease 
  Page 207 - 215Antin JH, Bierer BE, Smith BR, Guinan EC, Provost MM, Ferrara JLM, Macklis RM, Tarbell NJ, Blythman H, Bouloux C, Zinniti LM, Bogart RE, Burakoff SJ, Weinstein HJEditors: R Gale and R Champhin.Alan R Liss, New York
• Hematology of Infancy and Childhood. 
  Chapter: Bone marrow transplantation 
  Page 317 - 344Weinstein HJ, Rappeport JM, Ferrara JLMEditors: DG Nathan and FA Oski.W.B. Saunders Co, PhiladelphiaEdition 4th,
• Clinical Bone Marrow Transplantation. 
  Chapter: Pathogenesis of graft versus host disease and graft-host tolerance 
  Page 52 - 61Ferrara JLMEditors: K Atkinson.Cambridge UP, New York
• Graft- vs-Host-Disease. 
  Chapter: Recent advances and future directions 
  Page 775 - 810ara JLM, Krenger W, Cooke KR, Pan LYEditors: JLM Ferrara.Marcel Dekker, New YorkEdition 2nd,
• Join now to see all

Abstracts/Posters

• The MAGIC Algorithm Probability (MAP): A Novel Laboratory Biomarker for the Response to Treatment of Acute Graft-Versus-Host Disease
  James L. M. Ferrara, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

• The Evolving Treatment Landscape for Patients with GvHD: More Options, More Decisions, Better Outcomes! 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Reining in Graft-Versus-Host Disease (GVHD) After Allogeneic Hematopoietic Cell Transplantation 
  60th American Society of Hematology Annual Meeting - 12/2/2018
• Reining in Graft-Versus-Host Disease (GVHD) After Allogeneic Hematopoietic Cell Transplantation 
  60th American Society of Hematology Annual Meeting - 12/1/2018
• Gastrointestinal GVHD: Biomarkers and Biology. 
  Emory University Grand Rounds, Atlanta, Georgia
• New Insights into Gastrointestinal Graft-versus-Host Disease. 
  Nobel Symposium, Karolinska Institutet, Stockholm, Sweden; John Radcliffe Hospital, Oxford
• Pathophysiology: Acute GVHD” and “Future Directions in GVHD. 
  GVHD Symposium: State of the Art, Bangkok, Thailand
• Have We Made Progress in the Treatment of GVHD? 
  Acute Leukemia Forum 2012, San Francisco, CA
• GvHD: Overcoming the Challenges 
  38th Annual Meeting of the European Group for Blood and Marrow Transplantation, Geneva, Switzerland
• Reg3?: A New Marker and Player in GvHD. 
  11th International Symposium: GvH/GvL 2012, Regensburg, Germany
• Can Biomarkers Make a Difference to the Treatment of GVHD? 
  Hadassah-Hebrew University Medical Center, Presentation to BMT Department, Jerusalem, Israel
• Graft-vs-Host Disease: New insights into an old, thorny problem. 
  13th Scientific Meeting of the Israel Association for Bone Marrow Transplantation,Chaim Sheba Med
• Novel Diagnosis and Therapeutic Strategies in Allogeneic Bone Marrow Transplantation. 
  Oxford University, Hematology Department, Oxford, UK
• The Metabolism of Our Immune System: Advances in Immunotherapy of Cancer. 
  Seminar of All Souls College, Oxford University, Oxford, UK
• Advances in the Diagnosis and Treatment of GVHD. 
  University of Kansas Cancer Center Grand Rounds, Kansas City, MO
• Cell Metabolism in GVHD. 
  Catholic University Medical Center Symposium, Buenos Aires, Argentina
• Metabolic Studies of Immune Responses. 
  Queensland Institute for Medical Research Seminar, Brisbane, Australia
• Biomarker Development for BMT Complications. 
  Queensland Institute for Medical Research Seminar, Brisbane, Australia
• How to Write a Killer Scientific Paper. 
  Amgen Hematology Symposium, Sydney, Australia
• Advances in GVHD Diagnosis and Treatment. 
  King’s College Hematology Seminar, London, England
• Innate and Adaptive Immune System Interactions in GVHD. 
  Oncology Research Seminar, University-Regensburg, Germany
• New Insights into Gastrointestinal GVHD. 
  Special Seminar, Hospital Bambino Gesu, Rome, Italy
• Acute GVHD treatment: Improving Response and Survival. 
  Dresden Symposium, Dresden, Germany
• Can Treg Prevent GVHD Without Losing GvL? 
  The International Congress on Controversies in Stem Cell Transplantation and Cellular Therapies
• Advances in GI GVHD. 
  5th Raisa Gorbacheva Memorial Meeting, St. Petersburg, Russia
• Bioenergetic Strategy to Treat Graft Versus Host Disease. 
  Hartwell Annual Meeting, Memphis, TN
• Join now to see all

Other

• Lab Focus: James Ferrara. 
  Ferrara JLM, BSBMT News
  http://www.bsbmt.org/pages/232-Newsletter_7_April_10
• Michigan in the News. 
  Ferrara J
  http://www.ur.umich.edu/update/archives/100107
  The University Record. Retrieved
• New test could discern serious condition early after bone marrow transplant. 
  Ferrara JLM, Science News
• New drug could reduce death rates of bone marrow disease. 
  Brustar, R, The Michigan Daily
  http://www.michigandaily.com
• Hints on Writing a Successful Grant. 
  Ferrara JLM, The Bayer Hemophilia Awards Program
  http://hwww.bayer-haemophilia-awards.com/hints_on_writing.cfm
• Join now to see all